arrow
S

Susan DeWolf

Memorial Sloan Kettering Cancer Center
H指数:25
被引数:2,656

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An information-theoretic framework for inferring T cell dynamics from single-cell RNA and T cell receptor sequencing

基于信息论框架,从单细胞RNA和T细胞受体测序推断T细胞动态

2026-11-050
OAAI
Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant

移植物抗宿主病预防措施塑造造血细胞移植后的T细胞生物学和免疫重建

2026-10-210
PRE
Elevated levels of TNF and its targets characterize better-risk older acute myeloid leukemia patients

TNF及其靶点的升高水平是风险较低的老年急性髓系白血病患者的特征

Leukemia
IF13.4
2026-04-010
OAAI
Author Correction: Age-related epithelial defects limit thymic function and regeneration

作者更正: 年龄相关的上皮缺陷限制了胸腺功能和再生

2026-03-130
OAAI
CD371-Targeted CAR T-cells Secreting Interleukin-18 Exhibit Robust Expansion and Clear Refractory Acute Myeloid Leukemia

CD371靶向CAR T细胞分泌白细胞介素18,表现出强大的增殖能力并清除难治性急性髓系白血病

Blood
IF23.1
2025-08-290
PRE
CD371-targeted CAR T cells secreting interleukin-18 exhibit robust expansion and clear refractory acute myeloid leukemia

靶向CD371的CAR T细胞分泌白介素-18,表现出强大的扩增能力并清除难治性急性髓系白血病

Blood
IF23.1
2025-08-290
PRE
Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse posttransplant

骨髓和血液显示出不同的免疫重建模式,并与移植后的复发存在关联。

2025-06-140
OAAI
Recirculating regulatory T cells mediate thymic regeneration through amphiregulin following damage

循环调节性T细胞通过 amphiregulin 介导胸腺损伤后的再生

IMMUNITY
IF26.3
2025-02-011
OAAI
Dual-Vector-Transduction with Single-Step Magnetic Selection (Zip-sort) Increases Transgenic Payloads to Enhance CAR T Cell Activity

双向量转导结合单步磁选(Zip-sort)可增加转基因载荷以增强CAR T细胞活性

BLOOD
IF23.1
2024-11-050
PRE
Single-Cell Spatial Transcriptomics Identifies Lymphoid Aggregates with Location-Specific Alterations of Adaptive Immune Cells in Human MDS Bone Marrow

单细胞空间转录组学识别出在人类MDS骨髓中具有位置特异性改变的适应性免疫细胞的淋巴聚集物

BLOOD
IF23.1
2024-11-050
PRE
Age-related epithelial defects limit thymic function and regeneration

年龄相关性上皮缺损限制胸腺功能和再生

2024-08-073
OAAI
SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study
2024-05-277
PRE
Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy

造血干细胞移植和嵌合抗原受体T细胞治疗受者中SARS-CoV2 Omicron变体的结果和管理

2024-01-019
OAAI
Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouse
2023-07-267
OA
SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study
2023-05-0116
OAAI
MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT

MAIT和Vδ2非常规T细胞由多种肠道微生物组支持,并与同种异体HCT后患者的良好预后相关

2022-05-2525
OA
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer

CD8 T细胞有助于COVID-19和血液系统癌症患者的生存

2021-05-20309
OAAI
Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation
2020-11-16100
OA